medica glp-1 coverage Paving the way for expanded | Insights & Events Medicare GLP-1 Drug Coverage -
Description
95% CI 0.580.75)
Do not gamble with timing
Burping (belching) explained Burping, also known as eructation, is a known side effect of many GLP-1 receptor agonists, including Mounjaro, Wegovy, Ozempic (semaglutide), and Saxenda (liraglutide)
Most studies are observational, and long-term data on drug-induced NAION risk with GLP-1 use is still emerging
Novo Nordisk announced that the company will launch its diabetes treatment Ozempic, containing the active ingredient semaglutide, as a non-reimbursed drug starting on Thursday
Marso et al., 2016
